1294P A final analysis of a phase II study of durvalumab immediately after completion of chemoradiotherapy in unresectable stage III non–small-cell lung cancer: TORG1937 (DATE study)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 34; pp. S746 - S747
Main Authors Kondo, T., Kubota, K., Nakamichi, S., Misumi, T., Murakami, S., Shiraishi, Y., Imai, H., Harada, D., Isobe, K., Itani, H., Takata, S., Wakui, H., Taniguchi, Y., Ikeda, S., Asao, T., Furuya, N., Hosokawa, S., Kobayashi, Y., Takiguchi, Y., Okamoto, H.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.10.2023
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2023.09.772